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Abstract: Thermally processed rhizomes of Atractylodes macrocephala (RAM) have a long history of use
in traditional Chinese medicine (TCM) for treating various disorders, and have been an integral part
of various traditional drugs and healthcare products. In TCM, herbal medicines are, in most cases,
uniquely processed. Although it is thought that processing can alter the properties of herbal medicines
so as to achieve desired functions, increase potency, and/or reduce side effects, the underlying chemical
changes remain unclear for most thermally processed Chinese herbal medicines. In an attempt to shed
some light on the scientific rationale behind the processes involved in traditional medicine, the RAM
processed by stir-frying with wheat bran was investigated for the change of chemical composition.
As a result, for the first time, five new chemical entities, along with ten known compounds, were
isolated. Their chemical structures were determined by spectroscopic and spectrometric analyses.
The possible synthetic pathway for the generation of such thermally-induced chemical entities was
also proposed. Furthermore, biological activity evaluation showed that none of the compounds
possessed cytotoxic effects against the tested mammalian cancer and noncancer cell lines. In addition,
all compounds were ineffective at inhibiting the growth of the pathogenic microorganisms.
Keywords: Atractylodes macrocephala; wheat bran; processing; NMR; atractylon derivatives; isolation
and identification

1. Introduction
The rhizome of Atractylodes macrocephala Koidz (RAM)—called Baizhu in traditional Chinese
medicine (TCM)—is a well-known herbal medicine. It was documented in the earliest existing book
on TCM—“Shen Nong’s Materia Medica” written during the Han Dynasty (A.D. 25-220). RAM has
been traditionally used for the treatment of various disorders, such as loss of appetite, diarrhea, limb
weakness, gastrointestinal dysfunction, immune dysfunction, diabetes, and some chronic inflammatory
diseases [1]. It was reported that RAM is used in more than 835 TCM preparations, as well as an integral
part of more than 4340 classic prescriptions for treating chronic diseases [1]. Indeed, RAM is considered
a functional food, a tonic, and a constituent of various health products purported for promoting
digestion, alleviating fatigue, improving sleeping, enhancing immunity, and treating alimentary
anemia [2]. RAM is traditionally used in its processed form which is commonly achieved by stir-frying
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raw RAM with wheat bran [3,4]. This type of processing technique, known as Pao-Zhi in TCM, has
been widely used for the preparation of Chinese Materia Medica [5] with a long history. It is believed
that after processing, property and function of remedies can be changed, medical potency can be
increased, and/or toxicity and side effect can be reduced. The practice of processing RAM can date back
to the Tang dynasty (A.D. 618–907) [6], and the earliest processing protocol for RAM by stir-frying with
wheat bran was recorded in the famous Sheng Ji Zong Lu, the TCM prescription book written in A.D.
1117. This processing method is also currently documented in the Chinese Pharmacopeia [7]. Although
processed RAM is commonly used as an ingredient of various Chinese medicines and health products,
so far, the chemical compositional change as a result of processing has not been clearly delineated.
Extensive phytochemical and pharmacological studies have been conducted on raw RAM, revealing
the presence of volatile organics, sesquiterpenoids, triterpenoids, polyacetylenes, coumarins and
phenylpropanoids, flavonoids and their glycosides, steroids, benzoquinones, and polysaccharides [1].
Among them, sesquiterpene lactones (i.e., atractylenolids I, II, and III) are considered to be the
characteristic and bioactive constituents of RAM [8,9]. Efforts have been previously undertaken to
investigate the changes occurring in the chemical components of RAM before and after processing by
utilizing HPLC, GC/MS, and other analytical techniques. Substantial changes in the concentration of
constituents, including those in essential oil, as well as the eudesmane-type sesquiterpenoids (such as
atractylon, atractylnolides I, II, and III, etc.), were observed [3,10–13]. These changes can be explained
as the result of evaporation, conversion, and/or degradation by heating, due to their physicochemical
properties such as volatility and instability [13,14]. Nevertheless, in continuation of the quest to probe the
overall integrity of botanical preparations by using NMR-based metabolomics to investigate the change
of chemical composition which occurred during processing, we observed that some new characteristic
signals appeared in the NMR spectra of the processed RAM, which suggested that some unknown
compounds could be generated during processing. Herein, the discovery of five new compounds
isolated from the RAM processed by stir-frying with wheat bran is reported. Their chemical structures
were determined by both spectroscopic and spectrometric analyses. In addition, a plausible mechanism
for the generation of these new compounds was proposed. Furthermore, their cytotoxic, antimicrobial,
and antileishmanial activities were evaluated.
2. Results and Discussion
2.1. Structure Elucidation
A previous study using a NMR-based metabolomics method to investigate the effects of processing
on the Chinese herbal medicine Flos Lonicerae revealed that the NMR approach can provide not only
a holistic view on the change of chemical composition during processing, but also the information
on identity of individual components [5]. In the present study, with the aid of information obtained
from the NMR-based metabolomic analyses of RAM before and after processing, we could narrow the
scope of isolation targets to the hexane partition fraction and its sub-fractions based on new signals of
interest observed in their NMR spectra.
Compound 1 was obtained as a white amorphous powder. Its molecular formula was established
as C31 H40 O2 based on its high-resolution atmospheric pressure chemical ionization mass data
(HR-APCI-MS, m/z = 445.3134 [M + H]+ ). From its 13 C-NMR spectrum, only 16 resonance signals
were observed, suggesting 1 might contain two symmetrical sub-structures with 15 carbons for each
structure. Referring to the multiplicity-edited HSQC spectrum, the signals in the 13 C spectrum were
assigned to two methyls, six methylenes, one exocyclic methylidene, one aliphatic methine, one
aliphatic quaternary, and five olefinic carbons (Table 1). The 1 H-NMR spectrum showed signals of
methyl groups at δH 1.87 (s) and 0.76 (s), exocyclic methylidene at δH 4.68 and 4.84, aliphatic methine at
δH 2.10 (m), five methylenes in the range of δH 1.40–2.50, and one methylene at δH 3.82 (s). The integral
value of the peak of methylene at δH 3.82 was found to be only 1/3 of the value for the singlet peak of
methyl at δH 0.76 or 1.87, indicating that this methylene is the group bridging the two symmetrical
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moieties together with each moiety containing 15 carbons (Figure 1). The HMBC spectrum of 1 reveals
the cross-peaks of the methyl signal at δH 0.76 (H-14,140 ) with the carbon signals at δC 42.0 (C-1,10 ),
δC 45.7 (C-5,50 ), δC 39.2 (C-9,90 ) and δC 36.7 (C-10,100 ). Additionally, the cross-peaks of the methyl
signal at δH 1.87 (H-13,130 ) with the carbon signals at δC 116.6 (C-7,70 ), δC 114.3 (C-11,110 ), and δC
145.0 (C-12,120 ), and the cross-peaks of the exocyclic methylidene at δH 4.68 and 4.84 (H-15,150 ) with
the carbon signals at δC 37.3 (C-3,30 ), δC 150.0 (C-4,40 ), and δC 45.7 (C-5,50 ) were observed in the
HMBC spectrum. These observations suggested that the 15-carbon moiety had a furanoeudesmane
carbon skeleton in the structure as in atractylon, which is a known furanosesquiterpene isolated
from RAM in significant quantity [15]. The analysis of the 1 H-1 H COSY spectrum further confirmed
the assignment. The nuclear Overhauser effect (NOE) interactions between H-14 (140 ) and H-2β
(20 β)/H-6β (60 β), but no NOE interaction between H-14 (140 ) and H-5 (50 ), were observed in the
NOESY spectrum, indicating that the trans-fused A/B ring junction and α,β-orientation of H-5 (50 )
and Me-14 (140 ) in the furanoeudesmane skeleton was the same as atractylon. Observations of
HMBC correlations of the methylene signal at δH 3.82 (H-16) to C-11 (110 ) at δC 114.3 and C-12
(120 ) at δC 145.0 in the HMBC spectrum indicated that the two symmetrical moieties were linked
together through the methylene group attaching to C-11 and C-110 . Accordingly, 1 was identified
to be bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methane,
trivially named methylene-biatractylon.
Compound 2 was obtained as a white amorphous powder. As determined from the [M + H]+
peak at m/z = 459.3267 in HR-ACPI-MS, 2 has a molecular formula of C32 H42 O2 with 12 degrees
of unsaturation (DOU). Compound 2 has the same number of DOU as compound 1, but has an
additional CH2 in molecular formula. The 1 H NMR and HSQC spectra of 2 exhibit similar signal
patterns as those of 1, respectively, i.e., the signals of methyl groups at δH 1.82/1.76 (s) and 0.75/0.77 (s),
exocyclic methylidene at δH 4.68 and 4.84, aliphatic methine at δH 2.10 (m), six methylenes in the
range of δH 1.40–2.50. A significant difference lies in that one methylene at δH 3.82 (s) was observed
for 1, but one aliphatic methine at δH 4.17 (q) and one methyl at δH 1.57 (d) were observed for 2
(Table 1). The 13 C-NMR spectrum of 2 also displays a similar signal pattern as that of 1. A significant
difference between 2 and 1 is the presence of one methine carbon at δC 30.1 and one methyl carbon at
δC 18.1 in 2, corresponding, respectively, to the proton signals at δH 4.17 and δH 1.57. The analyses
of the COSY and HSQC spectra confirmed the presence of an ethylidene unit in 2, instead of the
presence of a methylene in 1. Comparing 2 to 1, another difference in their 13 C spectra is that
slight splitting of carbon signals for the pair groups of C-1/10 , C-5/50 , C-9/90 , C-11/110 , C-13/130 , and
C-14/140 were observed for 2 but not for 1 (Table 1). Analyses of the HMBC and COSY spectra of
2 revealed that these pair of signals were attributed to the two atractylon moieties presented in 2.
Furthermore, the trans-fused A/B ring junction in the two atractylon moieties was confirmed by
the NOE observations from the NOESY spectrum. The HMBC correlations of the methyl protons
(Me-17) in the ethylidene unit at δH 1.75 with the carbons C-16 at δC 30.1, C-11 (110 ) at δC 112.9/113.0,
and C-12 (120 ) at δC 149.1, and the methine proton (H-16) in the ethylidene unit at δH 4.17 with the
carbons C-17 at δC 18.1, C-11 (110 ) at δC 112.9/113.0, and C-12 (120 ) at δC 149.1 indicated that the two
atractylon moieties were linked together through the methine in the ethylidene unit connecting at
C-11 and C-110 . On the basis of the aforementioned evidence, the structure of 2 was established to be
2,20 -(ethane-1,1-diyl)-bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan),
trivially named ethylidene-biatractylon.
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Table 1. 1 H-(500 MHz) and 13 C-(125 MHz) NMR data of compounds 1–5 (recorded in CDCl3 , ppm).
1

No. *

2

3

δC

δH

δC

δH

δC

1, 10 , (100 )

42.0 (t)

1.47, 1.68 (m, 4H)

41.9/42.0 (t)

1.49, 1.67 (m, 4H)

42.0 (t)

2, 20 , (200 )

23.6 (t)

3, 30 , (300 )

37.3 (t)

4, 40 , (400 )
5, 50 , (500 )

150.0 (s)
45.7 (d)

6, 60 , (600 )

21.2 (t)

7, 70 , (700 )
8, 80 , (800 )

116.6 (s)
146.9 (s)

9, 90 , (900 )

39.2 (t)

10, 100 , (1000 )
11, 110 , (1100 )
12, 120 , (1200 )

36.7 (s)
114.3 (s)
150.0 (s)

13, 130 , (1300 )

8.0 (q)

14, 140 , (1400 )

17.6 (q)

15, 150 , (1500 )

107.1 (t)

16

23.9 (t)

17
18
19
20
21

1.57, 1.63
(m, 4H)
2.02, 2.37
(m, 4H)

23.6 (t)
37.4 (t)

2.10 (m, 2H)

150.0 (s)
45.7/45.8 (d)

2.25, 2.32 (m, 4H)

21.1 (t)

1.56, 1.63
(m, 4H)
2.02, 2.37
(m, 4H)

39.2/39.3 (t)

7.8/8.0 (q)
17.6/17.7 (q)
107.1 (t)
30.1 (d)
18.1 (q)

41.9 (t)
23.6 (t)
37.3 (t)

2.10 (m, 2H)

2.10 (m, 2H)

149.9 (s)
45.6/45.7 (d)

2.25, 2.32 (m, 4H)

21.1 (t)

2.27, 2.34 (m, 4H)

21.1 (t)

116.8 (s)
147.6 (s)
2.42
(m, 4H)

36.7 (s)
113.0 (s)
149.1 (s)
1.87
(s, 6H)
0.76
(s, 6H)
4.68, 4.84
(d, 4H)
3.82
(s, 2H)

37.3 (t)

1.47, 1.66
(m, 4H)
1.55, 1.64
(m, 4H)
2.02, 2.38
(m, 4H)

δC

149.9 (s)
45.7 (d)

116.6 (s)
146.6 (s)
2.41
(m, 4H)

23.6 (t)

4
δH

39.2 (t)

7.8/7.9 (q)
17.6/17.7 (q)
107.1 (t)
36.1 (d)
153.1 (s)
107.2 (d)
110.2 (d)
141.4 (d)

1.48, 1.65
(m, 4H)
1.53, 1.63
(m, 4H)
2.02, 2.38
(m, 4H)
2.09 (m, 2H)
2.25, 2.32
(m, 4H)

116.8 (s)
147.6 (s)
2.42
(m, 4H)

36.7 (s)
115.2 (s)
144.7 (s)
1.76/1.82
(s, 6H)
0.75/0.77
(s, 6H)
4.68, 4.84
(d, 4H)
4.17
(q, 1H)
1.57 (d, 3H)

5
δH

39.2 (t)

6.07 (d, 1H)
6.30 (dd, 1H)
7.35 (d, 1H)

7.8/7.9 (q)
17.6/17.7 (q)
107.2 (t)
36.2 (d)
153.2 (s)
108.1 (d)
108.7 (d)
153.0 (s)
57.6 (t)

42.0 (t)
23.6 (t)
37.3/36.7 (t)
149.9/150.0 (s)
45.6/45.7 (d)
21.1 (t)

δH
1.47, 1.67
(m, 6H)
1.54, 1.64
(m, 6H)
2.02, 2.37
(m, 6H)
2.10 (m, 3H)
2.25, 2.32
(m, 6H)

116.8/116.7 (s)
147.3/147.0 (s)
2.40
(m, 4H)

36.7 (s)
115.2 (s)
144.5 (s)
1.80/1.81
(s, 6H)
0.75/0.76
(s, 6H)
4.68, 4.84
(d, 4H)
5.47
(s, 1H)

δC

39.2/39.1 (t)

2.40/2.39
(m, 6H)

36.7/36.4 (s)
115.1/114.9 (s)
144.8/144.3 (s)
1.79/1.80
(s, 6H)
0.75/0.76
(s, 6H)
4.67, 4.83
(d, 4H)
5.44
(s, 1H)
6.02 (d, 1H)
6.20 (d, 1H)
4.55 (s, 2H)

7.8/7.9/8.0 (q)
17.6/17.7 (q)
107.1/107.2 (t)
36.2 (d)
151.5 (s)
107.9 (d)
106.5 (d)
151.4 (s)
25.8 (t)

1.74/1.76/1.82
(s, 9H)
0.75/0.76
(s, 9H)
4.67, 4.83
(d, 6H)
5.42
(s, 1H)
5.93 (d, 1H)
5.89 (d, 1H)
3.86 (s, 2H)

(14′) in the furanoeudesmane skeleton was the same as atractylon. Observations of HMBC
correlations of the methylene signal at δH 3.82 (H-16) to C-11 (11′) at δC 114.3 and C-12 (12′) at δC 145.0
in the HMBC spectrum indicated that the two symmetrical moieties were linked together through
the methylene group attaching to C-11 and C-11′. Accordingly, 1 was identified to be bis(3,8αdimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methane,
trivially
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Figure
Figure1.1.Structures
Structuresofofcompounds
compounds1–15.
1–15.

Compound 3 was isolated as a white amorphous powder. Its molecular formula was determined as
C35 H42 O3 based on the HR-ACPI-MS data for the [M + H]+ peak at m/z = 511.3221, accounting for 15
degrees of unsaturation. Both the 1 H and 13 C signals of 3 in the upfield NMR chemical shift range showed
close similarities to those of 1 and 2, however, differences were observed in the downfield range. Four
additional carbon signals at δC 153.1, 141.4, 110.2, and 107.2 in the 13 C spectrum, and three additional
proton signals at δH 7.35 (d), 6.30 (dd), and 6.07 (d) in the 1 H spectrum were observed for 3, as compared
to 1 or 2. These signals were assigned to a furan ring (3 degrees of unsaturation) by the analyses of COSY
and HMBC spectra. Apart from these differences, the other signals displayed almost the same features as
in 1 or 2. The analyses of the 2D NMR spectra confirmed that 3 possessed a similar biatractylon skeleton
in its structure as was found in 1 and 2. Clear HMBC correlations of the methine proton (CH-16, with
proton and carbon signals at δH 5.47 (s) and δC 36.1, respectively) to C-17 at δC 153.1, C-18 at δC 107.2,
C-12 at δC 144.7, and C-11 δC 115.2 were observed, indicating that the furan ring and the two atractylon
moieties were linked together through this methine. Hence, the structure of 3 was determined to be
2,20 -(furan-2-yl-methylene)-bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]
-furan), trivially named furan-2-methanetriyl-biatractylon.
Compound 4 was obtained as a white amorphous powder. The [M + H]+ ion at m/z = 541.3299 in
the HR-ACPI-MS spectrum revealed its molecular formula as C36 H44 O4 , with the same 15 degrees of
unsaturation but with one more carbon, two more protons, and one more oxygen when compared
to 3. The 1 H-NMR spectrum of 4 showed almost the same features as that of 3, except for having
one more singlet signal at δH 4.55. The 13 C-NMR spectrum of 4 also displayed close similarity to
that of 3, except for the addition of an oxygenated methylene signal at δC 57.6 (corresponding to
the above signal at δH 4.55 in the HSQC spectrum) and the significant downfield shift of the olefinic
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carbon signal from δC 114.4 to 153.0. In the HMBC spectrum of 4, the protons of this oxygenated
methylene demonstrated clear correlations to the downfield-shifted carbons C-20 at δc 153.0 and
C-19 at δc 108.7, indicating its connection at C-20. No other significant differences were observed
when comparing the NOESY spectra of 4 and 3. Accordingly, the structure of 4 was established to
be (5-(bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methyl)
furan-2-yl)methanol, trivially named 5-furanmethanol-2-methanetriyl-biatractylon.
Compound 5 gave the [M + H]+ ion at m/z = 739.4719 in its HR-APCI-MS spectrum, which was
consistent with a molecular formula C51 H62 O4 possessing 21 degrees of unsaturation. As compared
with 4, compound 5 has six more degrees of unsaturation, 15 more carbons, and 18 more hydrogens in
the molecular formula. Both its 1 H and 13 C-NMR spectra exhibit similar signal patterns to those of 4,
respectively, except for the occurrence of additional peaks which were attributed to atractylon moieties.
Given that an atractylon moiety possesses 6 degrees of unsaturation, 15 carbons, and 19 hydrogens;
it is implied that 5 should contain three atractylon moieties in its structure. Further analyses of
the 1D and 2D NMR spectra confirmed the assignment, with the supporting data listed in Table 1.
The methine proton (H-16) at δH 5.42 displayed clear HMBC correlations to the carbon pairs C-11/110
at δC 115.1/115.1, C-12/120 at δC 144.8/144.8, as well as C-17 at δC 151.5 and C-18 at δC 107.9, indicating
two atractylon moieties were linked through this methine to the furan unit. The methylene protons
(H-21) at δH 3.86 showed clear HMBC correlations to the carbon C-11” at δC 114.9, C-12” at δC 144.3,
C-19 at δC 106.5, and C-20 at δC 151.4, revealing that the third atractylon moiety is linked through this
methylene to the furan unit. On the basis of the above information, the structure of 5 was assigned as
2,20 -((5-((3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methyl)
furan-2-yl)methylene)-bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]furan), trivially named furan-5-methanediyl-2-methanetriyl-triatractylon.
In addition to the aforementioned five new compounds, ten known compounds (6–15) were
also isolated from the processed RAM in the present study (Figure 1). They were identified as
5-(hydroxymethyl)furfural (6) [16], 5-(Hydroxymethyl)-2-(dimethoxymethyl)furan (7) [17], 2,3-dihydro3,5-dihydroxy-6-methyl-4-pyranone (8) [18], atractylon (9) [19], atractylenolide I (10) [20], atractylenolide
II (11) [20], atractylenolide III (12) [20], atractylenolide VII (13) [21], γ-selinene (14) [22], and
selina-4(14),7(11)-dien-8-one (15) [23] with comparing their spectroscopic data with those in the
literature. Compound 7 is likely an artifact from 6 since methanol was used in the isolation process.
Compound 8 was isolated from wheat [18], indicating that it might come from the wheat which was
used during the process.
2.2. Proposed Mechanism for the Formation of Compounds 1–5
To the best of our knowledge, this is the first report to delineate the possible role that processing
plays in producing new chemical entities and impacting the chemical composition of traditional
medicines. Five new compounds (1–5) were generated as a result of the processing of RAM by
stir-frying with wheat bran. A plausible rationale for the formation of new atractylon derivatives
(1–5) is outlined below. Both RAM and wheat bran contain fiber, polysaccharides, cellulose, resistant
starch, inulin, lignins, and oligosaccharides [1,24]. Thermal processing of cellulose, hemicellulose, and
other polysaccharides are known to produce significant amounts of diverse carbonyl compounds such
as formaldehyde [25], acetaldehyde, furfural, 5-hydroxymethylfurfural, etc. [26]. Isolation of major
quantities of both 5-(hydroxymethyl)furfural (6) and 5-(hydroxymethyl)-2-(dimethoxymethyl)furan (7)
from the processed RAM in this study further supports the formation of carbonyl compounds. On the
other hand, atractylon, the major sesquiterpene of A. macrocephala [15,27], can undergo electrophilic
reactions with the pyrolytic aldehyde products. For example, as shown in the proposed plausible
mechanism (Figure 2), atractylon would undergo electrophilic addition with RCHO (R can be hydrogen,
methyl, 2-furanyl, or 5-hydroxymethylfuranyl) to yield a carbinol intermediate (A). Under pyrolytic
conditions, the resulting carbinol would yield electrophilic species (B), which can be added to another
molecule of atractylon to form an adduct (C). Further deprotonation would yield thermally stable
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adducts 1–4. Moreover, compound 4 can undergo the same set of reactions (generation of electrophilic
to another molecule of atractylon and dehydration) to form compound 5.7 of 12
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2.3. Biological Activities of Compounds 1–5
2.3. Biological Activities of Compounds 1–5
The new compounds (1–5) were evaluated for their cytotoxicity to a panel of selected mammalian
The
new compounds (1–5) were evaluated for their cytotoxicity to a panel of selected
cancer and noncancer cell lines (SK-MEL, KB, BT-549, SK-OV-3, LLC-PK1, and Vero cells). None of the
mammalian
cancer and noncancer cell lines (SK-MEL, KB, BT-549, SK-OV-3, LLC-PK1, and Vero
compounds exhibited cytotoxic effects. All compounds were ineffective at inhibiting the growth of the
cells). None of the compounds exhibited cytotoxic effects. All compounds were ineffective at
pathogenic microorganisms including three fungi (C. albicans, C. neoformans, and A. fumigates) and five
inhibiting the growth of the pathogenic microorganisms including three fungi (C. albicans, C.
bacteria (S. aureus, methicillin-resistant S. aureus, E. coli, P. aeruginosa, and M. intracellulare). In addition,
neoformans, and A. fumigates) and five bacteria (S. aureus, methicillin-resistant S. aureus, E. coli, P.
the in vitro antileishmanial activity testing revealed that the compounds were not effective against
aeruginosa, and M. intracellulare). In addition, the in vitro antileishmanial activity testing revealed that
L. donavani. Even though the preliminary biological data of these interesting class of compounds are not
the compounds were not effective against L. donavani. Even though the preliminary biological data
encouraging, further biological studies on this class of compounds concerning other biological targets,
of these interesting class of compounds are not encouraging, further biological studies on this class
as well as SAR and medicinal properties need to be further investigated. In addition to biological
of compounds concerning other biological targets, as well as SAR and medicinal properties need to
activities, probing the comparative physicochemical properties of these polymeric compounds against
be further investigated. In addition to biological activities, probing the comparative physicochemical
monomeric atractylon might provide additional scientific rationale behind the traditional processes
properties of these polymeric compounds against monomeric atractylon might provide additional
associated with polyherbal formulations.
scientific rationale behind the traditional processes associated with polyherbal formulations.
3. Materials and Methods
3. Materials and Methods
3.1. General Experimental Procedures
3.1. General Experimental Procedures.
UV and IR spectra were obtained on a HP 8452A UV-Vis spectrometer (Hewlett-Packard, Palo Alto,
UV and
were
on a (Agilent
HP 8452A
UV-Vis spectrometer
Palo
CA, USA)
andIR
anspectra
Cary 630
FTIRobtained
spectrometer
Technologies,
Santa Clara,(Hewlett-Packard,
CA, USA), respectively.
Alto, CA, USA) and an Cary 630 FTIR spectrometer (Agilent Technologies, Santa Clara, CA, USA),
respectively. High-resolution mass spectra were obtained on an Agilent TOF LC/MS spectrometer
equipped with an atmospheric pressure chemical ionization (APCI) source and operated with the
Analyst QS 1.1 software for data acquisition and processing. NMR spectra were acquired on an
Agilent DD2-500 NMR spectrometer with a OneNMR probe at 500 MHz for 1H and 125 MHz for 13C
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High-resolution mass spectra were obtained on an Agilent TOF LC/MS spectrometer equipped with
an atmospheric pressure chemical ionization (APCI) source and operated with the Analyst QS 1.1
software for data acquisition and processing. NMR spectra were acquired on an Agilent DD2-500 NMR
spectrometer with a OneNMR probe at 500 MHz for 1 H and 125 MHz for 13 C using the pulse programs
provided by the Agilent Vnmrj 4.0 software. Silica gel (J. T. Baker, 40 µm for flash chromatography) and
Sephadex LH-20 were purchased from Fisher Scientific Co. (Waltham, MA, USA), and used for column
chromatographic separations. Biotage IsoleraTM Prime flash chromatography system (Biotage Co,
Charlotte, NC, USA) was used for further separation and purification. TLC was performed on silica
gel 60 GF 254 plates (Millipore Sigma, Burlington, MA, USA) with the TLC spots being observed at
254 nm, followed by spraying with 1% vanillin-H2 SO4 derivatization reagent.
3.2. Plant Material and Preparation
The rhizomes of A. macrocephala were purchased from the Harbin Medicine Group Shiyitang Chinese
Herbal Medicine Pharmaceutical Co. (Harbin City, Heilongjiang, China), and authenticated by Prof.
Zhenyue Wang at the Heilongjiang University of Chinese Medicine. A voucher specimen (No. 20150013)
was deposited in the Natural Products Laboratory, the School of Pharmacy of Heilongjiang University of
Chinese Medicine. The wheat bran, produced in Heilongjiang, was bought from the Harbin Medicinal
Materials market.
Processing of the rhizomes of A. macrocephala (2.5 kg) was conducted in the Processing Lab of
the Experimental Training Center in the Heilongjiang University of Chinese Medicine. Following the
processing protocol in the Chinese Pharmacopeia, the rhizomes were cut into slices and air-dried to
reach a constant weight. The wheat bran was first stir-fried in a cauldron with a temperature around
170 ◦ C until smoke appeared. The rhizome slices were then added into the cauldron with a ratio of the
rhizome to wheat bran of 1:4 (w/w), the mixture was stir-fried approximately 26 mins until the slices
turned to a yellow-brown color. Next, the processed rhizome slices were separated from the wheat
bran by a sifter.
3.3. Extraction and Isolation
The processed slices of rhizomes (2 kg) of A. macrocephala were powdered and extracted with
methanol (10 L × 3 times) using ultrasonic extraction for 1 hour for each cycle. After the solvent was
evaporated under reduced pressure, a total of 206.8 g of crude extract was obtained. The obtained
extract was suspended in water (3 L) and successively partitioned with hexane (3 L × 3 times) and
EtOAc (3 L × 3 times) to yield 44.4 g and 44.0 g partition fractions, respectively, after removal of
solvents in vacuo. The hexane fraction (44.0 g) was subjected to a silica gel column (CC) (820 g,
10 × 80 cm) for chromatographic fractionation, eluting with a hexane-CHCl3 solvent system by stepwise
increasing the polarity. The fractions were collected and combined based on TLC analysis to afford 18
fractions (Fr.1–18). Fr.5 (77.4 mg) was chromatographed on a Sephadex LH-20 column (45 g, 2 × 80 cm),
eluted with CHCl3 -MeOH (2.5:1) to yield compound 1 (12.1 mg). Fr.4 (77.1 mg) was first separated on
a Biotage chromatographic system (SNAP KP-Sil 100 g, eluting with hexane-CH2 Cl2 solvent system in
increasing CH2 Cl2 concentration from 15% to 80%), then purified by Sephadex LH-20 (45 g, 2 × 80 cm,
eluting with CHCl3 -MeOH 2:1) and silica gel column chromatography (CC) (9.25 g, 1.5× 40 cm,
stepwise eluting with hexane-CH2 Cl2 ) to give 2 (6.2 mg). Fr.8 (239.8 mg) was chromatographed on a
silica gel column (120 g, 4 × 80 cm) eluted with MeOH-CHCl3 (1:1), the targeted fraction was further
purified using a Sephadex LH-20 column (45 g, 2 × 80 cm), eluting with CHCl3 -MeOH while gradually
increasing the polarity, then further purified on a silica gel column (8.9 g, 2 × 40 cm) eluting with
hexane-CH2 Cl2 to yield 3 (13.5 mg). Fr.15 (4.20 g) was first chromatographed on a silica gel column
(120g, 4× 80 cm) eluting with hexane-EtOAc in increasing polarity, and then further purified on a
Sephadex LH-20 column (45 g, 2 × 80 cm) eluting with CHCl3 -MeOH (2:1) to yield 4 (7.4 mg). Fr.10
(297.1 mg) was treated similarly to that of Fr. 4 to obtain 5 (9.6 mg).
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3.4. Characterization of Compounds 1–5
Bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methane (1), (methylenebiatractylon), white amorphous powder. UV (MeOH): λmax (logε) = 231 (3.95) nm. IR (ART): V max =
2926.0, 2849.5, 1641.9, 1440.6, 1378.1, 1231.9, 1250.5, 1136.8, 889.0, 758.5 cm−1 . 1 H-NMR and 13 C-NMR
data see Table 1. HR-APCI-MS: m/z = 445.3134 [M + H]+ (calc’d. for C31 H41 O2 = 445.3106).
2,20 -(Ethane-1,1-diyl)-bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan) (2),
(ethylidene-biatractylon), white amorphous powder. UV (MeOH): λmax (logε) = 228 (4.02) nm.
IR (ART): V max = 2926.0, 2847.7, 1641.9, 1440.6, 1377.3, 1138.7, 889.0, 758.5 cm−1 . 1 H-NMR and
13 C-NMR data see Table 1. HR-APCI-MS: m/z = 459.3267 [M + H]+ (calc’d. for C H O = 459.3262).
32 43 2
2,20 -(furan-2-ylmethylene)-bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan)
(3) (furan-2-methanetriyl–biatractylon), white amorphous powder. UV (MeOH): λmax (logε) =
229 (4.12) nm. IR (ART): V max = 2924.1, 2849.5, 1641.9, 1377.3, 1440.6, 1340.0, 1250.5, 1231.9, 1181.6,
1136.8, 899.0, 762.2, 730.6 cm−1 . 1 H-NMR and 13 C-NMR data see Table 1. HR-APCI-MS: m/z = 511.3221
[M + H]+ (calc’d. for C35 H43 O3 = 511.3212).
(5-(bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methyl)furan-2yl)methanol (4) (5-furanmethanol-2-methanetriyl-biatractylon), white amorphous powder. UV (MeOH):
λmax (logε) = 230 (4.17) nm. IR (ART): V max = 2924.1, 2845.8, 1641.9, 1440.6, 1377.3, 1250.5, 1233.7,
1136.8, 1013.8, 889.0, 786.5, 758.5 cm−1 . 1 H-NMR and 13 C-NMR data see Table 1. HR-APCI-MS: m/z =
541.3299 [M + H]+ (calc’d. for C36 H45 O4 = 541.3318).
2,20 -((5-((3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan-2-yl)methyl)furan2-yl)methylene)bis(3,8α-dimethyl-5-methylene-4,4α,5,6,7,8,8α,9-octahydronaphtho-[2,3-β]-furan) (5) (furan5-methanediyl-2-methanetriyl-triatractylon), white amorphous powder. UV (MeOH): λmax (logε)
230 (4.30) nm. IR (ART): V max = 2953.9, 2924.1, 2853.3, 1459.3, 1377.3, 1272.9, 1136.8, 1123.8, 1073.5,
1015.7, 889.0 cm−1 . 1 H-NMR and 13 C-NMR data see Table 1. HR-APCI-MS: m/z = 739.4719 [M + H]+
(calc’d. for C51 H63 O4 = 739.4726).
The NMR, MS, UV, and IR spectra of above five compounds are presented in the Supplementary Materials,
which are available free of charge via the internet at https://www.mdpi.com/journal/molecules.
3.5. Biological Activity Assays
3.5.1. Cytotoxicity Assay
Cytotoxic activity was determined against four human cancer cell lines (SK-MEL, KB, BT-549,
and SKOV-3) and two noncancerous kidney cell lines (LLC-PK1 and Vero) as described earlier [28].
All cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA).
Each assay was performed in 96-well tissue culture-treated microplates. Cells were seeded at a density
of 25,000 cells/well and incubated for 24 h. Samples at different concentrations were added, and cells
were again incubated for 48 h. At the end of incubation, the cell viability was measured using a
tetrazolium dye (WST-8) which was converted to a water-soluble formazan product. The absorbance
was measured at 450 nm and the percent viability of sample treated cells was calculated in comparison
to the vehicle-treated cells. Doxorubicin was used as a positive control, while DMSO was used as the
negative (vehicle) control.
3.5.2. Antimicrobial Assays
Isolates were tested against a panel of 8 pathogenic organisms including three fungi
(Candida albicans ATCC 90028, Cryptococcus neoformans ATCC 90113, and Aspergillus fumigates ATCC
204305) and five bacteria (Staphylococcus aureus ATCC 29213, methicillin-resistant S. aureus ATCC 33591,
Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853, and Mycobacterium intracellulare
ATCC 23068). Microorganisms were obtained from the American Type Culture Collection. The assays
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were performed at the National Center for Natural Products Research (NCNPR), at the University
of Mississippi as a part of the antimicrobial screening program following a previously reported
method [29]. Drug controls, ciprofloxacin for bacteria and amphotericin B for fungi, were included in
each assay.
3.5.3. Antileishmanial Assay
Compounds were tested in vitro for their ability to inhibit Leishmania donovani, employing the
assay described by Jain et al. [30]. Amphotericin B was included as the drug control for L. donovani.
4. Conclusions
Pao-Zhi (frying and cooking of herbs) is an ancient pharmaceutic technique in TCM to facilitate
the use of herbal medicines for specific clinic needs [31]. Traditionally, most Chinese herbal medicines
undergo elaborate processing in order to become ingredients that are prescribed or utilized in the
manufacturing of TCM proprietary drugs [32]. Although the practice of processing has a long history,
the underlying mechanisms largely remain unclear for most Chinese herbal medicines. In the present
study, through the characterization of chemical profiles coupled with NMR metabolomics approach, the
chemical changes resulting from the traditional processing protocol associated with RAM preparation
were investigated. For the first time, five new chemical adducts, which were formed during processing
A. macrocephala with wheat bran, were isolated and their structures were identified. The findings
allowed us to gain valuable insights into the chemical reactions which occur during the processing
procedures. Processed RAM is widely used in various formulations of TCM drugs and health care
products. Stir-frying with wheat bran is one of the most widely used traditional processing methods
for RAM in TCM [12]. Although the processed RAM is listed as an item in the Chinese Pharmacopoeia,
there are currently no modern standardized processing protocols or quality control standards for the
processed RAM products. The findings of this study may provide useful information for developing
such standards with a scientific basis. Furthermore, as the change of chemical profile will inevitably
influence the associated pharmacological properties of processed RAM, further investigations of the
bio-activities of the newly generated compounds are needed.
Supplementary Materials: The supplementary information is available online. Figure S1.1: 1 H-NMR spectrum of
compound 1, Figure S1.2: 13 C-NMR spectrum of compound 1, Figure S1.3: HSQC spectrum of compound 1, Figure
S1.4: COSY spectrum of compound 1, Figure S1.5: HMBC spectrum of compound 1, Figure S1.6: HR-APCI-MS
spectrum of compound 1, Figure S1.7: IR spectrum of compound 1, Figure S1.8: UV spectrum of compound 1,
Figure S2.1: 1 H-NMR spectrum of compound 2, Figure S2.2: 13 C-NMR spectrum of compound 2, Figure S2.3:
HSQC spectrum of compound 2, Figure S2.4: COSY spectrum of compound 2, Figure S2.5: HMBC spectrum
of compound 2, Figure S2.6: HR-APCI-MS spectrum of compound 2, Figure S2.7: IR spectrum of compound 2,
Figure S2.8: UV spectrum of compound 2, Figure S3.1: 1 H-NMR spectrum of compound 3, Figure S3.2: 13 C-NMR
spectrum of compound 3, Figure S3.3: HSQC spectrum of compound 3, Figure S3.4: COSY spectrum of compound
3, Figure S3.5: HMBC spectrum of compound 3, Figure S3.6: HR-APCI-MS spectrum of compound 3, Figure
S3.7: IR spectrum of compound 3, Figure S3.8: UV spectrum of compound 3, Figure S4.1: 1 H-NMR spectrum of
compound 4, Figure S4.2: 13 C-NMR spectrum of compound 4, Figure S4.3: HSQC spectrum of compound 4, Figure
S4.4: COSY spectrum of compound 4, Figure S4.5: HMBC spectrum of compound 4, Figure S4.6: HR-APCI-MS
spectrum of compound 4, Figure S4.7: IR spectrum of compound 4, Figure S4.8: UV spectrum of compound 4,
Figure S5.1: 1 H-NMR spectrum of compound 5, Figure S5.2: 13 C-NMR spectrum of compound 5, Figure S5.3:
HSQC spectrum of compound 5, Figure S5.4: COSY spectrum of compound 5, Figure S5.5: HMBC spectrum
of compound 5, Figure S5.6: HR-APCI-MS spectrum of compound 5, Figure S5.7: IR spectrum of compound 5,
Figure S5.8: UV spectrum of compound 5.
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